Cat. No | MBA-0055 |
Name | Rabbit anti-Vesicular Monoamine Transporter 2 Antibody |
中文名字 | 兔抗泡状单胺转运蛋白2抗体 |
Description | The VMAT2 antiserum was quality control tested using standard immunohistochemical methods in rat brain and adrenal medulla using biotin/avidin-HRP techniques. |
Clonality | Polyclonal |
Isotype | IgG |
Host | Rabbit |
Quantity/Volume | 50ul/100 µL |
State | Liquid Whole Serum/antibody |
Reacts With | Rat |
Preabsorption Control | / |
Alternate Names | Monoamine transporter; Solute carrier family 18 member 2; Synaptic vesicular amine transporter; Vesicular amine transporter 2; Solute carrier family 18 A2 (vesicular monoamine transporter 2); SLC18A2; SVMT; VAT2; Svat; mnat, anti-VMAT2 |
RRID | AB_10013884 |
Immunogen | This information is proprietary to Mabioway |
Gene Symbol | Slc18a2 |
Entrez Gene ID | Entrez Gene: 25549 Rat |
NCBI Gene Aliases | / |
Sequence | Q05940 |
APPLICATION | |
Quality Control | The VMAT2 antiserum was quality control tested using standard immunohistochemical methods in rat brain and adrenal medulla using biotin/avidin-HRP techniques. Specificity of the antiserum was demonstrated by soluble preadsorption and western blot. Tissue staining is completely eliminated by pretreatment of the diluted antibody with an excess of rat VMAT2 peptide residues (496–515). Western blot analysis of immunoprecipitated rat brain homogenates demonstrates a dense immunoreactive band of approximately 55 kD and a minor band of approximately 75 kD. |
Tissue | Rat brain and adrenal medulla |
Perfusion Fixation | • Fixative: 4% paraformaldehyde in 0.1 M Phosphate buffer, pH 7.4; 500 mL over 20 min. |
Absorption Control | Rat VMAT2 (496–515) 25 mg/mL diluted antibody completely eliminates immunolabeling |
Sections | 10 µm cryostat |
Tissue Incubation | 18–24 hours at 2°–8°C |
Detection System | Bn/Av-HRP at dilutions recommended by the manufacturers. |
Suggested Dilution | 1/5,000–1/10,000 in PBS/0.3% Triton X-100 - Bn/Av-HRP immunohistochemistry |
NOTES | |
Special Instructions | It is recommended that the researcher perform a primary antibody dilution series using our dilution recommendations as a guideline. Note that a change in the fixation or buffering system from our protocol may change the configuration of the protein which could alter the reactivity with the tissue tested. |
Concentration | Not applicable. Antibody concentration is only relevant for purified antibodies. |
Storage | After reconstitution, use immediately or refrigerate at 2º–8ºC up to 2 days. For long-term storage, aliquot antibody and freeze at -15°C or lower. Avoid repeated freeze/thaw cycles |